Expanded Potential Stem Cell lines of pig and human cells established
A new approach has enabled researchers to create Expanded Potential Stem Cells (EPSCs) of both pig and human cells. These stem cells have the features of the very first cells in the developing embryo, and can develop into any type of cell. The research from LKS Faculty of Medicine of The University of Hong Kong (HKUMed), the Wellcome Sanger Institute, and the Friedrich-Loeffler-Institut in Germany offers incredible potential for studying human development and regenerative medicine.
The study published in Nature Cell Biology today (3rd June) is the first time scientists have been able to derive stem cells from early pig embryos. Domestic pigs have great potential for biomedical research because of their genetic and anatomical similarities to humans, including comparable organ sizes. Being able to genetically-modify pig stem cells will also be beneficial for animal health and food production.
Stem cells have the ability to develop into other cell types, and existing stem cell lines are already extremely useful for research into development, disease and treatments. However, currently available types of stem cell lines have limitations, and until now it has also not been possible to create embryonic stem cells from pigs and many other farm animals.
“Scientists have been attempting to derive porcine embryonic stem cells for decades without much success. With our Expanded Potential Stem Cell technology, we have now successfully derived and characterised stem cells from porcine preimplantation embryos. We have also established similar human stem cells. Our study represents a significant advance in stem cell research.”
Professor Pentao Liu, the leader of the study from the School of Biomedical Sciences and Stem Cell and Regenerative Medicine Consortium, HKUMed, and previously of the Wellcome Sanger Institute
Since human EPSCs can produce large numbers of placenta cells – called trophoblasts – they offer new opportunities to investigate pregnancy complications such as pre-eclampsia and miscarriages.
EPSCs come from culturing cells from the earliest stage of development, when the fertilised egg has only divided into 4 or 8 cells and the cells retain some totipotency – the ability to produce all cell types.
“These EPSC stem cells possess developmental potency that is not generally seen in conventional embryonic or induced pluripotent stem cells. They have the potential to produce all embryonic and extra-embryonic cell lines – including those in the placenta and yolk sac, turning back the development clock to the very earliest cell type. These cells will enable researchers to study early embryonic development, miscarriage and developmental disorders.”
Dr Xuefui Gao, a first author on the paper from HKUMed, and previously from the Wellcome Sanger Institute
The first EPSCs were created in 2017, when the group targeted key molecular pathways during very early development in mice. At these very earliest embryonic developmental stages, mammalian species are very similar and the cells are like a blank sheet of paper. This study has shown that it is possible to use the same approach to create human EPSCs and also to establish EPSCs from pigs – mammals that had previously been elusive to stem cell researchers.
“Our porcine EPSCs isolated from pig embryos are the first well-characterized pig cell lines worldwide. EPSC’s great potential to develop into any type of cell provides important implications for developmental biology, regenerative medicine, organ transplantation, disease modelling, and screening for drugs.”
Dr Monika Nowak-Imialek, an author on the paper from the Friedrich-Loeffler-Institut (FLI) in Germany
The Latest on: Stem cells
via Google News
The Latest on: Stem cells
- NICE Amends Guidance on Haematopoietic Stem Cell Transplantation During the Pandemicon August 4, 2020 at 11:57 pm
The National Institute for Health and Care Excellence (NICE) has amended its recommendations on advice and testing for COVID-19 among patients undergoing haematopoietic stem cell transplantation and ...
- Gingivitis Ups Dementia Risk; COVID-19 Brain Fog; 'Alarming' Stem Cell Tourism Complicationson August 4, 2020 at 8:32 am
(BBC) Foggy thinking, fatigue, persistent loss of smell: these are a few of the lingering neurologic maladies COVID-19 survivors continue to report. (Science) Philadelphia volunteers equipped with ...
- DOCK6 promotes chemo- and radioresistance of gastric cancer by modulating WNT/β-catenin signaling and cancer stem cell traitson August 4, 2020 at 4:42 am
Gastric cancer (GC) is the third leading cause of cancer-related mortality worldwide and prognosis after potentially curative gastrectomy remains poor. Administration of GC-targeting molecules in ...
- COVID-19 Impacts: Hematopoietic Stem Cells Transplantation (HSCT) Market will Accelerate at a CAGR of Almost 6% Through 2020-2024 | Demand for Personalized Medicine to Boost ...on August 3, 2020 at 11:00 pm
Technavio has been monitoring the hematopoietic stem cells transplantation (HSCT) market and it is poised to grow by USD 4.64 billion during 2020-2024, progressing at a CAGR of 6% during the forecast ...
- Global Stem Cell Source Market 2020 Applications, Market Size According to a Specific Product, Sales and Revenue by Region 2025on August 3, 2020 at 4:59 pm
Aug 04, 2020 (CDN Newswire via Comtex) -- The market research report entitled Global Stem Cell Source Market 2020 by Manufacturers, Type and Application, Forecast to 2025 presents an in-depth analysis ...
- Stem Cell Discovery Could Point to New Strategies for Glaucoma Therapyon August 3, 2020 at 5:00 am
Researchers hypothesize that neural progenitor cells may be protective in younger people, but contribute to age-related glaucoma progression via the inability to repair stress-related damage.
- Evidence for Stem Cell Transplantation as a Cure for HIV-1on August 3, 2020 at 4:53 am
A long-term follow-up study of a second London patient has demonstrated a successful stem cell transplantation from donors harboring an HIV-resistant gene.
- Human pluripotent stem cell-derived cardiomyocytes as a target platform for paracrine protection by cardiac mesenchymal stromal cellson August 3, 2020 at 2:30 am
Paradoxically, cell therapies to offset cardiomyocyte loss after ischemic injury improve long-term cardiac function despite a lack of durable engraftment. An evolving consensus, inferred ...
- Researchers discover stem cells in optic nerve that preserve visionon July 31, 2020 at 1:51 pm
Researchers have for the first time identified stem cells in the region of the optic nerve, which transmits signals from the eye to the brain. The finding presents a new theory on why the most common ...
- Neurologists warn of the danger of “stem cell tourism”on July 31, 2020 at 1:12 pm
To find out, a team of researchers surveyed neurologists who are likely to care for these patients, leveraging the American Academy of Neurology, which has over 20,000 members. Only a tiny fraction of ...
via Bing News